Analyst Ratings February 3, 2026

BofA Elevates Popular to Buy, Sees Durable Mid-Teens ROTCE

Firm raises price target to $156 and lifts 2026 EPS on stronger credit metrics and net interest margin gains

By Hana Yamamoto BPOP
BofA Elevates Popular to Buy, Sees Durable Mid-Teens ROTCE
BPOP

BofA Securities moved Popular, Inc. (NASDAQ: BPOP) from Neutral to Buy and increased its price target to $156 from $141, citing expected sustainable mid-teens return on tangible common equity and improving credit trends. The broker also boosted its 2026 EPS estimate and highlighted stronger-than-anticipated Q4 2025 net interest margin as a key driver.

Key Points

  • BofA Securities upgraded Popular (BPOP) from Neutral to Buy and raised its price target to $156 from $141 - impacts banking and financial services sector.
  • BofA expects sustainable mid-teens ROTCE, forecasting about 14% in 2026 and 2027 - relevant to investor assessments of profitability and capital returns.
  • BofA raised 2026 EPS to $14.53 (up 3%), citing better-than-expected Q4 2025 net interest margin expansion; Banco Popular reported Q4 2025 EPS of $3.53, beating estimates by 16.5%.

Overview

BofA Securities upgraded Popular, Inc. (NASDAQ: BPOP) from Neutral to Buy and raised its 12-month price target to $156.00 from $141.00. The brokerage framed the upgrade around confidence that Popular can sustain mid-teens return on tangible common equity (ROTCE), estimating roughly 14% for both 2026 and 2027.


Credit and earnings drivers

BofA pointed to better-than-expected credit quality as a central reason for the more constructive stance. The firm noted that credit metrics are normalizing, but said the pace of that normalization is not alarming. BofA links the improvement in asset performance in part to a recovery in economic activity across the markets where Popular operates.

On the earnings front, BofA increased its 2026 EPS projection for Popular by 3%, to $14.53 from $14.08. That revised estimate sits about 2% above consensus and is driven largely by stronger-than-anticipated net interest margin expansion reported in the fourth quarter of 2025.


Valuation and market context

Despite upward earnings-per-share revisions, BofA observed that Popular’s share multiple has lagged those improvements, implying potential for further price appreciation even though the stock is trading near its 52-week high. The brokerage’s assessment suggests a gap between fundamental earnings revisions and current market multiple compression.


Recent company results and outlook

Banco Popular released fourth-quarter 2025 results showing EPS of $3.53, a 16.5% beat versus analyst expectations of $3.03. The company recorded a slight revenue shortfall in the quarter, however, and has guided to growth in both loan volume and net interest income for 2026.

Pre-market trading activity and the company’s forward-looking commentary have drawn attention from analysts and investors, according to the reporting. The article notes that specific analyst upgrades or downgrades tied to those results were not listed.


Takeaway

BofA’s upgrade centers on sustainable ROTCE near mid-teens, improving credit performance, and a favorable net interest margin trajectory. The brokerage raised its price target and EPS estimate, while noting a possible re-rating opportunity if the market multiple moves in line with rising earnings.

Risks

  • Credit normalization continues and remains a variable - if credit conditions change materially, earnings and returns could be affected (banking/financial services sector).
  • Slight revenue miss in Q4 2025 introduces uncertainty around top-line momentum even as EPS beat was reported (affects investors monitoring loan and fee growth).
  • Market multiple compression vs. EPS revisions: the stock’s valuation may not immediately reflect higher earnings, creating short-term price risk despite improved fundamentals.

More from Analyst Ratings

GLJ Research Lowers Daqo New Energy to Sell, Sets $18.13 Target Feb 3, 2026 JPMorgan Sticks With Overweight on Disney Despite Near-Term Earnings Questions Feb 3, 2026 Canaccord Lifts WAVE Life Sciences Price Target to $43 After Regaining WVE-006 Rights Feb 3, 2026 Acadia Shares Slip After CHMP Signals Negative Vote on Trofinetide Marketing Application Feb 3, 2026 Canaccord Cuts Roblox Price Target to $140 Citing Margin Pressure as Engagement Rises Feb 3, 2026